Article
Alnylam's new Onpattro data raise fresh doubts in heart disease fight against Pfizer: analyst
Rating:
0.0
Views:
69
Likes:
1
Library:
1
Alnylam has offered a closer look at the data that could support Onpattro's quest to expand into a rare heart disease. | Alnylam has offered a closer look at the data that could support Onpattro's quest to expand into a rare heart disease. While an approval looks likely, some industry watchers have raised fresh doubts about the drug's commercial opportunity in its potential fight against Pfizer.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value